Moody's Corporation vs Nuwellis Inc — how do they compare? Moody's Corporation trades at $475 (market cap $82.52B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: Moody's Corporation is far larger — about 152026.5× Nuwellis Inc's market cap, and Moody's Corporation pays a 0.86% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MCO | NUWE | |
|---|---|---|
Market Cap | $82.52B | $542.80K |
Sector | Financials | Technology |
52-Week High | $539.61 | $220.50 |
52-Week Low | $412.23 | $1.42 |
Enterprise Value | $88.54B | -$1.27M |
Dividend Yield | 0.86% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →